The Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in a Complete Response Letter (CRL) for etripamil nasal spray (Cardamyst ™ ), an investigational ...

Intranasal delivery of a monoclonal IgG1 antibody targeting mugwort pollen protected mice from allergic rhinitis and asthma ...

Vaccine experts have developed an antibody that, when applied to the nose, intercepts allergens before they can trigger a ...

Market OverviewThe global Epilepsy Drugs Market is valued at USD 10.63 billion in 2024 and is projected to reach a value ...

Many brands make strong or extra-strength CBD gummies in broad- and full-spectrum options. See our top picks.

Approximately 40% of the European population are allergic to pollen, and their symptoms cause an estimated loss of 100 ...